Abingworth LLP has disclosed 19 total holdings in their latest 13F filing with the SEC for the portfolio
date of 2022-12-31. The current portfolio value is calculated to be $307.00 Mil. The turnover rate is 0%.
In Abingworth LLP's current portfolio as of 2022-12-31, the top 5 holdings are
Vaxcyte Inc (PCVX), Verona Pharma PLC (VRNA), Vera Therapeutics Inc (VERA), HilleVax Inc (HLVX), Adicet Bio Inc (ACET),
not including call and put options.
Abingworth LLP did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the current and past 13F holdings for Abingworth LLP, as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at
52-week lows, etc.
Please visit the "Stock Picks" tab to see the latest guru trades and stock picks for Abingworth LLP, which include data from
13F quarterly reports, 13D/G beneficial ownership reports and form 4 insider ownership change reports.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Abingworth LLP.